Immunological Alterations in Haemophiliacs Treated with Lyophilized Factor VIII Cryoprecipitate from Volunteer Donors

Summary

We studied immune function in Belgian haemophiliacs treated with Factor VIII from volunteer donors. No patient had clinical evidence of immune deficiency. We found a decrease in T-helper cells (p <0.0005), in the ratio of T-helper over T-cytotoxic/ suppressor cells (1.72 ± 0.47 versus 2.24 ± 0.82 in controls, p <0.005) and in lymphocyte responsiveness to mitogens (p <0.05).

These findings could not be linked to the amount of F VIII received over the last year, the time since last F VIII administration, circulating immune complexes (54% positive patients, 7% positive controls, p <0.005), increased ALT levels, antibodies to cytomegalo-virus (85% of the patients, 45% of the controls, p <0.005), antibodies to Epstein-Barr virus, nor to the presence of HLA-DR 5 which was found in 56% of the haemophiliacs (20% of the overall Belgian population, p <0.005).

Either F VIII induces long lasting immunological alterations unrelated to AIDS, or haemophilia is itself associated with such changes.

Keywords

Haemophilia - Acquired immune deficiency syndrome - Factor VIII - T cell subsets - Immune complexes

• References

• 1 White GC, Lesesne HR. Hemophilia, hepatitis and the acquired immunodeficiency syndrome. Ann Intern Med 1983; 98: 403-404
• 2 Lederman MM, Ratnoff OD, Schillian JJ, Jones PK, Schacter B. Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med 1983; 308: 79-83
• 3 Metinove JE, Aster RH, Casper JT. et al The lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilised concentrates. N Engl J Med 1983; 308: 83-86
• 4 Goldsmith JC, Moseley PL, Monick M, Brady M, Hunninghake GW. The lymphocyte subpopulation abnormalities in apparently healthy patients with hemophilia. Ann Intern Med 1983; 98: 294-296
• 5 Luban NL C, Kelleher JF, Reaman GH. Altered distribution of T lymphocyte subpopulations in children and adolescents with haemophilia. Lancet 1983; 1: 503-505
• 6 Landay A, Poon MC, Abo T, Stagno S, Lurie A, Cooper MD. Immunologic studies in asymptomatic haemophilia patients. Relationship to acquired immune deficiency syndrome J Clin Invest 1983; 71: 1500-1504
• 7 Lechner K, Niessner H, Bettelheim P, Deutsch E, Fasching I, Fuhrmann M, Hinterberger W, Kominger C, Neumann E, Liszka K, Knapp W, Mayr WR, Stingl G, Zeitlhuber U. T cell alterations in haemophiliacs treated with commercial clotting factor concentrates. Thromb Haemostas 1983; 50: 552-556
• 8 Delforgers JF. AIDS and preventive treatment in haemophilia. N Engl J Med 1983; 308: 94-95
• 9 Ceuppens JL, Gualde N, Goodwin JS. Phenotypic heterogeneity of the OKM₁-positive lymphocyte population. Reactivity of OKM₁ monoclonal antibody with a subset of the suppressor cytotoxic T cell population Cell Immunol 1982; 69: 150-165
• 10 Reinherz EL, Schlossman SF. Regulation of the immune response. Inducer and suppressor T lymphocyte subsets in human beings N Engl J Med 1980; 303: 370-373
• 11 Ledbetter JA, Evans RL, Lipinski M, Cunningham-Rundles C, Good RA, Herzenberg LA. Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/ suppressor sub-populations in mouse and man. J Exp Med 1981; 153: 310-323
• 12 Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody HNK₁ . J Immunol 1981; 127: 1024-1029
• 13 Van Rood JJ, Van Leeuw A, Ploem JS. Simultaneous detection of two cell populations by two colour fluorescence and application to the recognition of B cell determinants. Nature 1976; 262: 795-797
• 14 Hay FC, Nineham LJ, Roitt IM. Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C_1q . Clin Exp Immunol 1976; 24: 396-400
• 15 Henle W, Henle G, Horwitz CA. Infectious Mononucleosis and Epstein-Barr Virus - Associated Malignancies. Lennette EH, Schmidt NJ. (eds) In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. 5. APHA; Washington: 1979. pp 441-470
• 16 Saxinger C, Gallo RC. Application of the indirect ELISA microtest to the detection and surveillance of human T cell leukemia lymphoma virus (HTLV). Lab Invest 1983; 49: 371-377
• 17 Ludlam CA, Carr R, Veitch SE, Steel CM. Disordered immune regulation in haemophiliacs not exposed to commercial Factor VIII (Letter). Lancet 1983; 1: 1226
• 18 Kim HC, Saidi P, Ackley AM, Bringelsen KA, Gocke DJ. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease. Gastroenterology 1980; 79: 1159-1164
• 19 Kazatchkine MD, Sultan Y, Burton-Kee EJ, Monbray JF. Circulating immune complexes containing anti-F VIII antibodies in multi-transfused patients with haemophilia A. Clin Exp Immunol 1980; 39: 315-320
• 20 Friedman-Kien AE, Laubenstein LJ, Rubinstein P. et al Disseminated Kaposi’s sarcoma in homosexual men. Ann Intern Med 1982; 96: 693-700
• 21 Enlow RW, Roldan AN, Logalbo P, Mildvan D, Mathur V, Winchester RJ. Increased frequency of HLA-DR 5 in lymphadenopathy stage of AIDS (Letter). Lancet 1983; 1: 51-52
• 22 Schmidt RE, Budde V, Schäfer G, Stroehmann I. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura. Lancet 1981; 2: 475-576
• 23 Durandy A, Fischer A, Griscelli C. Dysfunction of mitogen stimulated T and B lymphocyte. Responses induced by gammaglobulin therapy J Clin Invest 1981; 67: 867-877
• 24 Fischer E, Lenhard V, Seiffert P, Kluge A, Johanssen R. Blood transfusion-induced suppression of cellular immunity in man. Hum Immunol 1980; 3: 187-194